J. Hughes

Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage.

J. Jett, A. Brody, M. Friedman, 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phospho-Akt Overexpression in Non–Small Cell Lung Cancer Confers Significant Stage-Independent Survival Disadvantage

J. Jett, A. Brody, M. Friedman, 2004, Clinical Cancer Research.

High dose epirubicin chemotherapy in untreated poorer prognosis small cell lung cancer.

S. Bicknell, J. Hughes, A. F. Henderson, 1990, Respiratory medicine.

• Cook GJR, O'Brien ME, Siddique M, Chicklore S, Loi HY, Sharma B, et al. Non-Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of (18)F-FDG Uptake at PET- Association with Treatment Response and Prognosis. Radiology. Radiological Society of North

J. Hughes, K. Gordon, 2016 .